Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03995979 · ClinicalTrials.gov registry record · NA

Inflammation and Protein Restriction

A NA study of Inflammation and Diet, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
12
Enrollment target
2
Study locations

NCT03995979 is a NA study of Inflammation and Diet that has completed, run by University of Florida. The registered enrollment target is 12 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03995979, a NA study of Inflammation and Diet, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
2
Study locations

Study Summary

There is strong scientific data that supports that short-term protein restrictive diets reduce surgical stress responses. The investigators are hoping to use the information collected from the blood serum and muscle tissue of healthy subjects to help understand the baseline and early changes in muscle energetic and cell-mediated inflammation. The study team hopes to use the data collected in this pilot study to compare with patients undergoing open abdominal aortic aneurysm (AAA) repair in a future study

Interventions

  • OTHER 4 Day Protein Restricted Diet

Study Locations (2)

Florida

  • Malcom Randall VA Medical Center - Gainesville
  • UF Health---Vascular Surgery - Gainesville

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2019-09-09
Est. Completion 2024-02-16
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT03995979

The ClinicalTrials.gov registry entry for NCT03995979 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (96% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which 4 Day Protein Restricted Diet is the first listed.

NCT03995979 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03995979 about?

NCT03995979 is a clinical study titled "Inflammation and Protein Restriction". There is strong scientific data that supports that short-term protein restrictive diets reduce surgical stress responses. The investigators are hoping to use the information collected from the blood serum and muscle tissue of healthy subjects to help understand the baseline and early changes in musc...

What is the current status of trial NCT03995979?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-09-09. Estimated completion is 2024-02-16.

What conditions does trial NCT03995979 study?

This clinical trial studies the following conditions: Inflammation, Diet, Protein Restriction.

What interventions are being tested in trial NCT03995979?

The interventions under investigation include: 4 Day Protein Restricted Diet (OTHER).

Who is sponsoring clinical trial NCT03995979?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03995979 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.